IF: 1.578
Cite Score:
1.45
THOMSON REUTERS - SCOPUS

Combination Therapy of Interferon-alpha (PDferon B®) and Ribavirin for Chronic Hepatitis C

AUTHORS

Seyed Moayed Alavian 1 , * , Ali Kabir 2 , Behzad Hajarizadeh 2 , Mohsen Nayebpour Pharm 3 , bashir hajibeigi 2 , Taher Doroudi 2 , F. E. Baralle 4

AUTHORS INFORMATION

1 Baqiyatallah Hospital Tehran Hepatitis Center, Tehran, IR-Iran

2 Methodology and statistics consultant Tehran Hepatitis Center, Tehran, IR-Iran

3 Assistant professor of pharmacology, Faculty of pharmacy, Tehran University of Medical Sciences, Tehran, IR-Iran

4 Professor and Director of International Center for Genetic Engineering and Biotechnology, Trieste, Italy

ARTICLE INFORMATION

Hepatitis Monthly: 4 (6); e92940
Published Online: May 31, 2004
Article Type: Research Article
Received: May 05, 2019
Accepted: May 31, 2004

Crossmark

CHEKING

READ FULL TEXT
Abstract

Keywords

Interferon Ribavirin Hepatitis C Treatment

© 2004, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Fulltext
References
  • 1. The References are available in the PDF file.
  • COMMENTS

    LEAVE A COMMENT HERE: